• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Science & Environment Medical Research

Many say they want answers, but fewer choose to know the truth

May 6, 2025
in Medical Research
Reading Time: 6 mins read
A A
0
Most people say they want to know their risk for Alzheimer's dementia, fewer follow through
6
SHARES
14
VIEWS
Share on FacebookShare on Twitter


Most people say they want to know their risk for Alzheimer's dementia, fewer follow through
A new study from WashU Medicine examines the choices healthy research volunteers make when given the opportunity to learn their risk of developing Alzheimer’s disease dementia. The researchers found a large discrepancy between the percentage of participants who said they would like to learn their risk if such estimates became available and the percentage who followed through to learn those results when given the actual opportunity. Credit: Sara Moser/WashU Medicine

As researchers make progress in understanding how Alzheimer’s disease develops, there are growing opportunities for healthy research participants to learn their risk of developing Alzheimer’s disease dementia in the future. While many organizations often advocate for investigators to share risk estimates with individual participants, there are ethical concerns around doing so, given that there are no medical interventions to change that risk.

A new study from Washington University School of Medicine in St. Louis examines the choices such healthy research volunteers make when given the opportunity to learn about their risk of developing Alzheimer’s disease dementia. The study is published in JAMA Network Open.

The researchers found a large discrepancy between the percentage of participants who said they would like to learn about their risk if such estimates became available and the percentage who followed through to learn those results when given the actual opportunity.

The knowledge could help researchers design studies that offer the option of receiving results in ways that don’t pressure participants into making one choice over another. The study also emphasizes the importance of ensuring participants truly want their research results because hypothetical interest does not necessarily translate into wanting to learn one’s risk of Alzheimer’s disease dementia when it is actually offered.

“In general, there is movement toward giving research participants and patients their test results, even in situations when nothing can be done with those results,” said senior author Jessica Mozersky, Ph.D., an assistant professor of medicine at the Bioethics Research Center and an investigator at the Charles F. and Joanne Knight Alzheimer Disease Research Center, both at WashU Medicine.

“But our study suggests that in sensitive cases—such as when estimating the risk of developing a debilitating and deadly disease—people should have the option to not know.”

In recent years, the National Academies of Sciences, Engineering and Medicine have recommended that research study designs in general include the option to return test results to participants, even when such results can’t be acted on. Similarly, a committee of study participants, their care partners and members of dementia advocacy organizations recently proposed a bill of rights for Alzheimer’s disease research participants that advocates for access to such results.

At the same time, ethical concerns remain because of the possibility of causing anxiety and other harm to participants who learn they are at high risk of developing a debilitating and incurable dementia. Unlike preventive options for individuals who learn they are at high genetic risk of certain cancers, for example, there are currently no approved preventive treatments or medical interventions available to stave off Alzheimer’s disease dementia.

Most people say they want to know their risk for Alzheimer's dementia, fewer follow through
In a recent study, researchers at WashU Medicine found a large discrepancy between the percentage of participants who said they would like to learn their risk of developing Alzheimer’s disease dementia if such estimates became available and the percentage who followed through to learn those results when given the actual opportunity. Credit: Sara Moser/WashU Medicine

To get a clearer picture of who declines Alzheimer’s disease dementia risk results and why, Mozersky and her colleagues turned to long-running research at WashU Medicine’s Knight Alzheimer Disease Research Center. Since 1979, the Memory & Aging Project has provided a framework to study brain function in participants as they age. Over the decades, the project has evolved and expanded into several long-running studies of the development and progression of Alzheimer’s disease, including the development of biomarker tests to determine risk.

For the current study, Mozersky’s team focused on cognitively normal volunteers who underwent a battery of tests, including genetic tests, blood draws and brain scans, from which researchers could estimate their probability of developing Alzheimer’s disease dementia over the following five years.

Participants originally joined the long-term study understanding that they would not have the option to receive their own risk results. Even so, Mozersky said, over the years many have expressed a theoretical interest in learning their results.

The study, co-led with Sarah M. Hartz, MD, Ph.D., a professor of psychiatry at WashU Medicine, offered results to a subset of participants in the Memory & Aging project—274 participants—to assess the psychological impact of learning their risk, and the factors they consider when making that decision.

Before deciding, participants received an information guide explaining how risk is estimated and listing some examples of pros and cons of learning their results. For example, on the pro side, some people may learn their risk is lower than they might have expected. And if biomarker test results suggest a participant is at high risk of developing Alzheimer’s disease dementia over the next five years, they may become eligible to participate in clinical trials of investigational prevention strategies.

On the other hand, knowledge of high risk may cause anxiety or complicate the purchase of some types of insurance.

When the results were theoretical, 81% of people in the larger, long-term research said they would choose to know. In contrast, when real results were offered to the 274 participants in the Memory & Aging Project, only 60% opted to receive them. Participants with a parental history of Alzheimer’s disease and participants who self-identified as African American were more likely than others to decline the results.

A sample of participants who declined to learn their results were interviewed afterward, and the most common reasons given included that knowing would be a burden to themselves or their family members, their own negative experiences and perceptions of Alzheimer’s disease dementia, that they feel good about their memory currently, that they’re already prepared for the disease, and that there is still uncertainty in predictions of disease risk.

“The lack of preventive treatments is also a big factor in declining to receive the results of biomarker tests among people without symptoms of Alzheimer’s disease dementia,” Mozersky said.

“When we conducted interviews with some participants to better understand their choice not to know, many said that a new effective treatment might change their mind, if it became available.”

Because the results are only available through research studies, they are not added to the participant’s medical record by the investigators. Still, such results could end up in a patient’s medical record if a participant shares them with their doctor.

“We plan to continue our research into the complexities of these questions, especially as returning results to research participants becomes more common, even if those results can’t be acted on yet,” Mozersky said.

More information:
Research participant interest in learning results of biomarker tests for Alzheimer disease, JAMA Network Open (2025). DOI: 10.1001/jamanetworkopen.2025.2919

Provided by
Washington University in St. Louis


Citation:
Alzheimer’s risk: Many say they want answers, but fewer choose to know the truth (2025, May 6)
retrieved 6 May 2025
from https://medicalxpress.com/news/2025-05-alzheimer-truth.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



Most people say they want to know their risk for Alzheimer's dementia, fewer follow through
A new study from WashU Medicine examines the choices healthy research volunteers make when given the opportunity to learn their risk of developing Alzheimer’s disease dementia. The researchers found a large discrepancy between the percentage of participants who said they would like to learn their risk if such estimates became available and the percentage who followed through to learn those results when given the actual opportunity. Credit: Sara Moser/WashU Medicine

As researchers make progress in understanding how Alzheimer’s disease develops, there are growing opportunities for healthy research participants to learn their risk of developing Alzheimer’s disease dementia in the future. While many organizations often advocate for investigators to share risk estimates with individual participants, there are ethical concerns around doing so, given that there are no medical interventions to change that risk.

A new study from Washington University School of Medicine in St. Louis examines the choices such healthy research volunteers make when given the opportunity to learn about their risk of developing Alzheimer’s disease dementia. The study is published in JAMA Network Open.

The researchers found a large discrepancy between the percentage of participants who said they would like to learn about their risk if such estimates became available and the percentage who followed through to learn those results when given the actual opportunity.

The knowledge could help researchers design studies that offer the option of receiving results in ways that don’t pressure participants into making one choice over another. The study also emphasizes the importance of ensuring participants truly want their research results because hypothetical interest does not necessarily translate into wanting to learn one’s risk of Alzheimer’s disease dementia when it is actually offered.

“In general, there is movement toward giving research participants and patients their test results, even in situations when nothing can be done with those results,” said senior author Jessica Mozersky, Ph.D., an assistant professor of medicine at the Bioethics Research Center and an investigator at the Charles F. and Joanne Knight Alzheimer Disease Research Center, both at WashU Medicine.

“But our study suggests that in sensitive cases—such as when estimating the risk of developing a debilitating and deadly disease—people should have the option to not know.”

In recent years, the National Academies of Sciences, Engineering and Medicine have recommended that research study designs in general include the option to return test results to participants, even when such results can’t be acted on. Similarly, a committee of study participants, their care partners and members of dementia advocacy organizations recently proposed a bill of rights for Alzheimer’s disease research participants that advocates for access to such results.

At the same time, ethical concerns remain because of the possibility of causing anxiety and other harm to participants who learn they are at high risk of developing a debilitating and incurable dementia. Unlike preventive options for individuals who learn they are at high genetic risk of certain cancers, for example, there are currently no approved preventive treatments or medical interventions available to stave off Alzheimer’s disease dementia.

Most people say they want to know their risk for Alzheimer's dementia, fewer follow through
In a recent study, researchers at WashU Medicine found a large discrepancy between the percentage of participants who said they would like to learn their risk of developing Alzheimer’s disease dementia if such estimates became available and the percentage who followed through to learn those results when given the actual opportunity. Credit: Sara Moser/WashU Medicine

To get a clearer picture of who declines Alzheimer’s disease dementia risk results and why, Mozersky and her colleagues turned to long-running research at WashU Medicine’s Knight Alzheimer Disease Research Center. Since 1979, the Memory & Aging Project has provided a framework to study brain function in participants as they age. Over the decades, the project has evolved and expanded into several long-running studies of the development and progression of Alzheimer’s disease, including the development of biomarker tests to determine risk.

For the current study, Mozersky’s team focused on cognitively normal volunteers who underwent a battery of tests, including genetic tests, blood draws and brain scans, from which researchers could estimate their probability of developing Alzheimer’s disease dementia over the following five years.

Participants originally joined the long-term study understanding that they would not have the option to receive their own risk results. Even so, Mozersky said, over the years many have expressed a theoretical interest in learning their results.

The study, co-led with Sarah M. Hartz, MD, Ph.D., a professor of psychiatry at WashU Medicine, offered results to a subset of participants in the Memory & Aging project—274 participants—to assess the psychological impact of learning their risk, and the factors they consider when making that decision.

Before deciding, participants received an information guide explaining how risk is estimated and listing some examples of pros and cons of learning their results. For example, on the pro side, some people may learn their risk is lower than they might have expected. And if biomarker test results suggest a participant is at high risk of developing Alzheimer’s disease dementia over the next five years, they may become eligible to participate in clinical trials of investigational prevention strategies.

On the other hand, knowledge of high risk may cause anxiety or complicate the purchase of some types of insurance.

When the results were theoretical, 81% of people in the larger, long-term research said they would choose to know. In contrast, when real results were offered to the 274 participants in the Memory & Aging Project, only 60% opted to receive them. Participants with a parental history of Alzheimer’s disease and participants who self-identified as African American were more likely than others to decline the results.

A sample of participants who declined to learn their results were interviewed afterward, and the most common reasons given included that knowing would be a burden to themselves or their family members, their own negative experiences and perceptions of Alzheimer’s disease dementia, that they feel good about their memory currently, that they’re already prepared for the disease, and that there is still uncertainty in predictions of disease risk.

“The lack of preventive treatments is also a big factor in declining to receive the results of biomarker tests among people without symptoms of Alzheimer’s disease dementia,” Mozersky said.

“When we conducted interviews with some participants to better understand their choice not to know, many said that a new effective treatment might change their mind, if it became available.”

Because the results are only available through research studies, they are not added to the participant’s medical record by the investigators. Still, such results could end up in a patient’s medical record if a participant shares them with their doctor.

“We plan to continue our research into the complexities of these questions, especially as returning results to research participants becomes more common, even if those results can’t be acted on yet,” Mozersky said.

More information:
Research participant interest in learning results of biomarker tests for Alzheimer disease, JAMA Network Open (2025). DOI: 10.1001/jamanetworkopen.2025.2919

Provided by
Washington University in St. Louis


Citation:
Alzheimer’s risk: Many say they want answers, but fewer choose to know the truth (2025, May 6)
retrieved 6 May 2025
from https://medicalxpress.com/news/2025-05-alzheimer-truth.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.


Tags: Health ResearchHealth Research NewsHealth ScienceMedicine ResearchMedicine Research NewsMedicine Science
Previous Post

Lawyer signals teen accused in Georgia school shooting that killed 4 is likely to plead guilty

Next Post

Second-life batteries from electric buses to be used for grid-scale energy storage

Related Posts

Cooper Health System reports data security breach

Cooper Health System reports data security breach

May 28, 2025
4
woman uncomfortable

Most young women suffer from itching, irritation, pain and other symptoms in genital area, Brazilian study finds

May 28, 2025
4
Next Post
Alex-Charr-of-Connected-Energy-with-the-Forsee-Power-batteries

Second-life batteries from electric buses to be used for grid-scale energy storage

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024

Police ID man who died after Corso Italia fight

December 23, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0
1

Altimetrik nears Rs 5,100 crore acquisition of SLK Software todayheadline

May 28, 2025
We’re about to unlock the secrets of ancient human brains

We’re about to unlock the secrets of ancient human brains todayheadline

May 28, 2025

Cosmic Dawn Screening – NASA

May 28, 2025
Hanford site’s radioactive waste could soon be treated for disposal

Hanford site’s radioactive waste could soon be treated for disposal

May 28, 2025

Recent News

1

Altimetrik nears Rs 5,100 crore acquisition of SLK Software todayheadline

May 28, 2025
0
We’re about to unlock the secrets of ancient human brains

We’re about to unlock the secrets of ancient human brains todayheadline

May 28, 2025
4

Cosmic Dawn Screening – NASA

May 28, 2025
4
Hanford site’s radioactive waste could soon be treated for disposal

Hanford site’s radioactive waste could soon be treated for disposal

May 28, 2025
4

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Cybersecurity
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

1

Altimetrik nears Rs 5,100 crore acquisition of SLK Software todayheadline

May 28, 2025
We’re about to unlock the secrets of ancient human brains

We’re about to unlock the secrets of ancient human brains todayheadline

May 28, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co